论文部分内容阅读
目的探讨痰热清注射液治疗急性支气管肺炎患者的临床疗效。方法选取2014年10—12月收治的急性支气管肺炎患者资料86例,按随机数字表法将其分为观察组与对照组,各43例。对照组患者给予常规治疗,观察组患者在对照组基础上加用痰热清注射液治疗。比较两组患者的临床疗效。结果观察组患者的退热时间、咳嗽消失时间、啰音消失时间以及住院时间均明显短于对照组,差异均有统计学意义(均P<0.05);观察组患者总有效率明显高于对照组,差异有统计学意义(P<0.05)。结论痰热清注射液在急性支气管肺炎治疗中具有重要的临床应用价值,可快速缓解临床症状,缩短住院时间,提高治疗效果。
Objective To investigate the clinical efficacy of Tanreqing injection in the treatment of patients with acute bronchial pneumonia. Methods Totally 86 patients with acute bronchial pneumonia admitted from October to December in 2014 were divided into the observation group and the control group according to the random number table method, with 43 cases in each group. Patients in the control group were given routine treatment. Patients in the observation group were treated with Tanreqing Injection on the basis of the control group. The clinical efficacy of the two groups was compared. Results The patients in observation group had significantly shorter antipyretic time, cough disappearance time, rales disappearance time and hospitalization time than those in control group (all P <0.05). The total effective rate in observation group was significantly higher than that in control group Group, the difference was statistically significant (P <0.05). Conclusion Tanreqing injection has an important clinical value in the treatment of acute bronchopneumonia, which can quickly relieve clinical symptoms, shorten the length of hospital stay and improve the therapeutic effect.